New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
West Pharmaceutical Services, Inc.
WST
Shape
US Flag

NYSE

22B

Medical - Instruments & Supplies

307.92USD
Shape-22.73 ( -6.87%)
favorite-chart

Relative Strenght

15
favorite-chart

Volume Buzz

137%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

26%

Quote Panel

Shape
Updated October 28, 2024
1W 7.51 % 1M 2.59 % 3M 6.94 % 1Y -3.51 %

Key Metrics

Shape
  • Market Cap

    22.34B


  • Shares Outstanding

    72.42M


  • Share in Float

    72.00M


  • Dividende

    0.84


  • Earning Date

    No Data


  • Price Target

    307.92


  • Average Volume

    565404


  • Beta

    1.007


  • Range

    265.0-413.7


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.westpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

45.55x

P/E Ratio

7.77x

P/S Ratio

8.15x

P/B Ratio

0.1

Debt/Equity

17.4%

Net Margin

$6.7

EPS

How WST compares to sector?

P/E Ratio

Relative Strength

Shape

WST

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape310%

2025-Revenue

$7.49

Shape300%

2025-EPS

$834M

Shape417%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

upgrade

Previous: Not converted

2024-02-07

Now: Buy

Morgan Stanley

upgrade

Previous: Not converted

2023-06-16

Now: Buy

Bank of America Securities

upgrade

Previous: Not converted

2023-06-16

Now: Buy

Stephens

upgrade

Previous: Overweight

2023-04-11

Now: Positive

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-13%

1.77
vs 2.04

Q1.23

arrow
arrow

-14%

1.98
vs 2.3

Q2.23

arrow
arrow

-15%

2.11
vs 2.47

Q3.23

arrow
arrow

+6%

2.16
vs 2.03

Q4.23

arrow
arrow

+3%

1.83
vs 1.77

Q1.24

arrow
arrow

-21%

1.56
vs 1.98

Q2.24

arrow
arrow

-28%

1.52
vs 2.11

Q3.24

arrow
arrow

-14%

1.85
vs 2.16

Q4.24

arrow
arrow

-4%

1.75
vs 1.83

Q1.25

arrow
arrow

+7%

1.67
vs 1.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-3%

708.7M  vs 730.8M

Q1.23

arrow
arrow

0%

716.6M  vs 720M

Q2.23

arrow
arrow

-2%

753.8M  vs 771.3M

Q3.23

arrow
arrow

+9%

747.4M  vs 686.9M

Q4.23

arrow
arrow

+3%

732M  vs 708.7M

Q1.24

arrow
arrow

-3%

695.4M  vs 716.6M

Q2.24

arrow
arrow

-7%

702M  vs 753.8M

Q3.24

arrow
arrow

0%

746.9M  vs 747.4M

Q4.24

arrow
arrow

+2%

745.4M  vs 732M

Q1.25

arrow
arrow

+5%

730.7M  vs 695.4M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+4%

0.04
vs 0.05

Q1.23

arrow
arrow

+5%

0.05
vs 0.04

Q2.23

arrow
arrow

+6%

0.06
vs 0.05

Q3.23

arrow
arrow

+6%

0.06
vs 0.06

Q4.23

arrow
arrow

+5%

0.05
vs 0.06

Q1.24

arrow
arrow

+4%

0.04
vs 0.05

Q2.24

arrow
arrow

+4%

0.04
vs 0.04

Q3.24

arrow
arrow

+5%

0.05
vs 0.04

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

641

641
vs 657

-2%

Q4.22

arrow
arrow

648

648
vs 641

1%

Q1.23

arrow
arrow

705

705
vs 648

9%

Q2.23

arrow
arrow

743

743
vs 705

5%

Q3.23

arrow
arrow

778

778
vs 743

5%

Q4.23

arrow
arrow

801

801
vs 778

3%

Q1.24

arrow
arrow

795

795
vs 801

-1%

Q2.24

arrow
arrow

783

783
vs 795

-2%

Earnings Growth

Latest News